Caliper Life Sciences

ComGenex, Inc. Announces Appointment of Executive Vice President

Date Posted: Friday, April 04, 2003

Print Email to a friend

ComGenex, Inc. has announced the appointment of Dr. Klaus Frobel as Executive Vice President of Medicinal Chemistry and Discovery Technologies. Dr. Frobel joins ComGenex from his position as Global Head of Medicinal Chemistry at Bayer AG for the research centres in Europe, USA and Japan. Dr. Laszlo Urge, CEO, Comgenex commented, "He [Dr. Frobel] combines chemical, pharmacological, therapy-targeted and technological expertise which is unique even within the pharmaceutical industry. Klaus will not only help in the integration of our discovery technologies, but will also be responsible for advancing the technology of our spin-off company, Thales Nanotechnologies, Inc."

Further Information: http://www.comgenex.com



Related news from our archive

ComGenex Announces Extension of the Medicinal Chemistry Synthesis Space
ComGenex has tested and completed the initial phase of the integration of ozonolyzis.

ComGenex Announces Extension of the Medicinal Chemistry Synthesis Space
ComGenex has tested and completed the initial phase of the integration of ozonolyzis.

ComGenex signs up two Japanese distribution agents

Comgenex extends into Chemical Genomics

ComGenex and Infocom Agreement